MARIA C. FREIRE, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BIOGEN INC.

Filing Date Source Excerpt
2021-04-23 Dr. Freire has served as President and Executive Director of the Foundation for the National Institutes of Health... New Nominee for Biogen Board Committee: Compensation and Management Development Committee.
2022-04-29 Dr. Freire served as President and Executive Director of the Foundation for the National Institutes of Health... Biogen Board Committee: Compensation and Management Development... 2021 Director Compensation: Maria D. Freire Fees Earned or Paid in Cash $81,154, Stock Awards $270,413, Total $351,567.
2023-04-28 Maria C. Freire, Ph.D. Director Since: 2021 Age: 68 Biogen Board Committee: Compensation and Management Development 2022 Director Compensation Table: Maria C. Freire Fees Earned or Paid in Cash: $140,000 Stock Awards: $270,246 All Other Compensation: $3,543 Total: $413,789

EXELIXIS, INC.

Filing Date Source Excerpt
2019-04-11 Dr. Freire holds a Ph.D. in Biophysics from the University of Virginia and a B.S. from the Universidad Peruana Cayetano Heredia in Lima, Peru.
2020-04-09 Dr. Freire should continue to serve as a director of Exelixis due to her training as a scientist, her knowledge and experience with respect to medical research, the pharmaceutical industry and government healthcare policymaking, as well as her leadership experience in the public sector.
2021-04-15 Dr. Freire should continue to serve as a director of Exelixis due to her training as a scientist, her knowledge and experience with respect to medical research, the pharmaceutical industry and government healthcare policymaking, as well as her leadership experience in the public sector.
2022-04-14 Dr. Freire holds a Ph.D. in Biophysics from the University of Virginia and a B.S. from the Universidad Peruana Cayetano Heredia in Lima, Peru.
2024-04-18 Dr. Freire holds a Ph.D. in Biophysics from the University of Virginia and a B.S. from the Universidad Peruana Cayetano Heredia in Lima, Peru.

Data sourced from SEC filings. Last updated: 2025-12-06